Centrifugal abdominal lipodystrophy

From WikiMD's Wellness Encyclopedia

Centrifugal Abdominal Lipodystrophy

Illustration of Centrifugal Abdominal Lipodystrophy

Centrifugal Abdominal Lipodystrophy (CAL), also known as Lipoatrophia annularis or Lipoatrophia semicircularis, is a rare, benign condition characterized by the localized loss of subcutaneous fat tissue in the abdominal region. The condition is often associated with repetitive physical trauma or pressure to the affected area.

Etiology[edit | edit source]

The exact cause of CAL is unknown, but it is believed to be multifactorial. Some researchers suggest that it may be related to repetitive minor trauma or pressure to the abdominal wall, while others propose a possible hormonal or metabolic cause. Endocrine disorders, diabetes, and obesity have also been associated with the condition.

Clinical Presentation[edit | edit source]

Patients with CAL typically present with a semicircular or annular band of fat loss in the abdominal region. The affected area is often asymptomatic, but some patients may experience mild discomfort or pain. The condition does not typically affect the patient's overall health or lifespan.

Diagnosis[edit | edit source]

Diagnosis of CAL is primarily based on clinical examination and patient history. Imaging studies such as CT scans or MRI may be used to confirm the diagnosis and rule out other conditions.

Treatment[edit | edit source]

There is currently no specific treatment for CAL. Management of the condition primarily involves avoiding repetitive trauma or pressure to the affected area. In some cases, cosmetic surgery may be considered to improve the appearance of the affected area.

Epidemiology[edit | edit source]

CAL is a rare condition, with only a few hundred cases reported in the medical literature. It affects both men and women, but appears to be more common in women. The condition typically develops in adulthood, but cases in children have also been reported.

See Also[edit | edit source]

References[edit | edit source]


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.